Unichem Laboratories Limited (BOM:506690)
476.40
+12.35 (2.66%)
At close: Jul 7, 2026
Unichem Laboratories Market Cap
Unichem Laboratories has a market cap or net worth of 33.54 billion as of July 7, 2026. Its market cap has decreased by -20.71% in one year.
Market Cap
33.54B
Enterprise Value
35.65B
Revenue
22.02B
Ranking
n/a
PE Ratio
13.29
Stock Price
476.40
Market Cap Chart
Since July 30, 2001, Unichem Laboratories's market cap has increased from 5.81B to 33.54B, an increase of 477.58%. That is a compound annual growth rate of 7.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 33.54B | 7.94% |
| Dec 31, 2025 | 31.07B | -40.43% |
| Dec 31, 2024 | 52.16B | 82.07% |
| Dec 29, 2023 | 28.65B | 28.87% |
| Dec 30, 2022 | 22.23B | 27.19% |
| Dec 31, 2021 | 17.48B | -5.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 69.37B |
| Bliss GVS Pharma | 54.25B |
| Gufic Biosciences | 38.38B |
| Novartis India | 36.02B |
| Morepen Laboratories | 33.30B |
| Kwality Pharmaceuticals | 27.53B |
| Hikal | 26.85B |
| Venus Remedies | 23.20B |